The highly specific restriction endonucleases SalI and BamI produce DNA Cohen et al. (20). Immunity to colicin El (ImmE1+) and the ability to produce colicin El (colicin E1+) were determined by the overlay procedure (21). Drug concentrations used were 25 ,ug/ml for tetracycline (Tc) and kanamycin (Km) and 35 sg/ml for ampicillin (Ap). All strains carrying D. melanogaster DNA were handled under "low risk" conditions as defined in the "Summary
cleaves various DNAs about once every 8 kb (kilobases), as compared to about once every 4 kb for EcoRI (16, 18) . The resulting fragments have cohesive termini, and can be joined to one another in head-to-tail, head-to-head, and probably tail-to-tail orientation. Another highly specific restriction endonuclease that produces cohesive termini is BamI, from Bacillus amyloliqefaciens H (G. Wilson B restriction-and modification-negative (rBm-MB) prolinegalactose-streptomycinR recA- (19) ; our isolate, obtained from J. Morrow , is also lactose-arabinose-arginine-. Plasmid pSF2124 was isolated and kindly provided to us by M. So, R. Gill, and S. Falkow. Plasmid pML21, constructed by V. Hershfield, D. Helinski, and H. Boyer, was obtained from K. Backman, and pSC101 was obtained from J. Morrow. pDmll13 is a pML21/EcoRI-D. melanogaster/EcoRI chimera that has one BamI site in the 6.5 kb fragment of D. melanogaster DNA. E. coli was transformed with covalently closed circular DNA or ligase reaction mixtures as described by Cohen et al. (20) . Immunity to colicin El (ImmE1+) and the ability to produce colicin El (colicin E1+) were determined by the overlay procedure (21) . Drug concentrations used were 25 ,ug/ml for tetracycline (Tc) and kanamycin (Km) and 35 (10) . The lengths of pSF2124 (11.0 kb) and pML21 (10.5 kb) were estimated from their mobilities relative to covalently closed circular pSC101 and a pSC101-ColEl hybrid on 0.9% agarose gels. Distances between restriction sites, indicated in kb, were determined by electrophoresis of the appropriate digests through 0.9% agarose gels with X/EcoRI fragments (30) as markers, or through 3.2% agarose gels using X/HaeIII (18, 31) and simian virus 40/HaeIII (32) fragments as markers. The orientation of pSC101 relative to pML21 in pGM437 and pGM439 was determined by cleavage with EcoRI; pGM437 gave three fragments with lengths of 13.6 kb (68% of the DNA), 3.4 kb (20%), and 2.5 kb (12%), whereas pGM439 gave three fragments with lengths of 10.5 kb (57%), 5.9 kb (32%), and 3.4 kb (11%). The orientation of pSC101 relative to pSF2124 in pGM706 was shown by BamI cleavage, which yielded two fragments with lengths of 13.9 kb (71%) and 6.4 kb (29%). Cleavage of pGM16 with SalI gave two fragments with lengths of 13.9 kb (73%) and 6.0 kb (27%). The site and orientation of insertion shown in the figure was confirmed by the isolation (described in the text) of a BamI-resistant, 15.5 kb deletion plasmid, pGM16A405. EcoRI cleavage of this plasmid gave two fragments with lengths of 12.2 kb (75%) and 3.4 kb (25%), whereas SalI cleavage gave two fragments with lengths of 13.5 kb (86%) and 1.9 kb (14%). mM and ligase to 0.1-0.4 units/pmol of DNA fragment, and the mixture was held at 12.7°for [16] [17] [18] [19] [20] [21] [22] [23] [24] hr.
For the preparation of DNA, cells harboring plasmids replicating under stringent control (see below) were grown in Penassay broth plus antibiotics to 2 to 4 X 109/ml. Cells harboring plasmids replicating under relaxed control were grown to 2 to 4 X 108/ml, treated with 250 ,ug/ml of chloramphenicol to stop the synthesis of chromosomal but not of plasmid DNA, and incubated an additional [8] [9] [10] [11] [12] [13] [14] [15] [16] hr. Covalently closed circular plasmid DNA was prepared by Brij lysis followed by centrifugation in a cesium chloride-ethidium bromide density gradient (24) . The preparation of D. melanogaster embryo DNA and X DNA and procedures for analytical and preparative agarose gel electrophoresis have been described (18) .
RESULTS
Construction of pSCIOl/SalI-pML21/SaII hybrid plasmids We found two E. coli plasmids, pSC101 and pML21, that had a single site for Sall. pSC101 (1, 25 ) is a 9.2 kb tetracycline resistance plasmid that replicates under stringent control; i.e., it is present at 1-2 copies per chromosome in logarithmically growing cells, and its replication requires new protein synthesis but not the product of the polA gene, DNA polymerase 1 (26, 27) . pML21 is a 10.5 kb plasmid consisting of a DNA fragment specifying kanamycin resistance joined to a mini-ColEl fragment (1, 3 (3, 28) .
To determine the effect of inserting new DNA at the SalI site of pSC101 and of pML21, the two plasmids were mixed, cleaved with SalI, treated with DNA ligase, then introduced into strains HMS49 and HMS51 polAI by transformation. Selection for pSC101/SalI-pML21/SalI hybrids was based on the following logic. Insertion into pSC101, depending on location, might inactivate tetracycline resistance (TcR) or replication (RepSC101), but not both. The SalI site on pML21 is located within the kanamycin resistance fragment ( Fig. 1 Plasmid DNA prepared from these clones by centrifugation in an ethidium bromide-cesium chloride density gradient was examined by restriction endonuclease cleavage and agarose gel electrophoresis (Fig. 2, gels, 4 , 5, 12, and 13). Both hybrid plasmids had a length of approximately 20 kb, as determined by their mobilities relative to appropriate markers, and both gave two equimolar fragments with lengths identical to those of pSC101 and pML21 after treatment with Sall. However, digestion with EcoRI showed that whereas both hybrids contain one copy each of the pSC101 and the pML21 fragment, they differ in the relative orientation of these fragments (Fig. 1) . In one hybrid, both Sall joints are head-to-tail, whereas in the other, one is head-to-head and the other is tail-to-tail. Construction of a pSC1O1/EcoRI-pSF2124/EcoRI hybrid plasmid vehicle for cloning DNA fragments produced by Sall These results indicated that insertion of DNA at the Sall site of pSC101 inactivates its expression of tetracycline resistance. We therefore sought to construct a hybrid cloning vehicle by joining pSC101 to a DNA fragment having an additional drug resistance marker but no additional SalI site. tetracycline, but not to the second drug, so that chimeras could be identified simply by replica plating. In addition, we wished the hybrid vehicle to carry the relaxed ColEl replicon, facilitating the preparation of large quantities of plasmid DNA.
We constructed such a hybrid by using pSF2124, a ColEl factor carrying ampicillin resistance. Insertion at the single EcoRI site of this plasmid interferes with colicin production but not with colicin immunity or ampicillin resistance (ref. 29 , and M. So, R. Gill, and S. Falkow, personal communication). Insertion at the single EcoRI site of pSCO1 does not interfere with its replication or with the expression of its tetracycline resistance gene (1, 8) . Therefore, a mixture of these two DNAs was cleaved with EcoRI, treated with DNA ligase, and introduced into E. coli C600. A TcR ApR ImmE1+ colicin El-clone was picked and designated C600 (pGM706). Plasmid DNA from this clone had a length of about 20 kb, as expected for a plasmid having one copy each of the 9.2 kb pSCI01 fragment and the 11.0 kb pSF2124 fragment (Fig. 2, gel 6 ). Treatment with EcoRI gave two equimolar fragments with the same lengths as pSF2124 and pSC10 (Fig. 2, gel 14) , whereas treatment with Sall gave a single fragment with a length of 20.2 kb (Fig. 3, gel 7) . Cleavage with BamI (not shown) demonstrated that the pSF2124 and pSC10 fragments are oriented relative to one another as shown in Fig. 1 . Construction of a pSC1O1/EcoRI-pML21/EcoRI hybrid plasmid vehicle for cloning DNA fragments produced by BamI Plasmid pSC101 also has a single BamI site, located 0.28 kb from the Sall site. It seemed likely that insertion at this site, just as at the Sall site, would inactivate the expression of tetracycline resistance. To test this idea, pSC101 was cleaved with BamI and ligated to a pML21/EcoRI-D. melanogaster/EcoRI chimera, pDml 13, which was cleaved with BamI at a single site within the D. melanogaster DNA. Transformation of HMS51 polAl with this mixture, but not with a control mixture of untreated DNAs, gave rise to kanamycin-resistant, colicin.-immune, tetracycline-sensitive clones, as would be expected if insertion at the BamI site of pSC101 had inactivated its expression of drug resistance but not its replication.
To construct a vehicle for the cloning of DNA fragments produced by BamI, pSC101 was joined to pML21, which has no BamI site. Plasmid pML21, which contains two EcoRI sites, was partially digested with EcoRI, and full length linear molecules were isolated on an agarose gel. These were ligated to EcoRI-cleaved pSC101, and the reaction mixture was used to transform GM4. A TcR KmR ImmEl+ colicin E1-clone was picked and designated GM4 (pGM16). Intact plasmid DNA from this strain had a length of about 20 kb (Fig. 2, gel 7) . Cleavage with EcoRI (Fig. 2, gel 15 ) gave three equimolar fragments with the same lengths as pSC101 and the kanamycin-resistance and mini-ColEl fragments of pML21, whereas cleavage with BamI (Fig. 3, gel 10 ) gave a single fragment with a length of 19.7 kb. Of the four possible configurations for the hybrid, that shown in Fig. 1 was shown to be correct by Sall cleavage and by studies of a deleted plasmid (described in the legend to Fig. 1) . Cloning of D. melanogaster DNA fragments The utility of pML21 and the two pSC101 hybrid plasmids as molecular vehicles has been verified by using them to clone D. melanogaster DNA fragments.
The effects of joining pSC101 to pML21 at their SalI sites, described above, suggested that foreign DNA could be inserted at the Sall site of pML21 without altering its expression of kanamycin resistance or its replication. Accordingly, a 40:1 weight:weight mixture of D. melanogaster embryo DNA and pML21 DNA was digested with SalI, treated with ligase, and transformed into GM4. Of 339 KmR clones analyzed, 14 had covalently closed circular DNA with a length at least 20% greater than pML21, as determined by agarose gel electrophoresis of total cell Sarkosyl-Pronase lysates. Plasmid DNA from four of the chimeric isolates was examined by cleavage with Sall (Fig. 3, gels 3-6 ). Each yielded two equimolar fragments; one had the length of pML21, the other had a length between 3.5 and 8.4 kb, and the sum of the fragment lengths was equal to the length of the intact DNA. EcoRI digests of these chimeras (not shown) gave two to four equimolar fragments, one of which had the same mobility as the mini-colEl fragment of the vehicle. These data demonstrate that each of the chimeras consists of a single Sall fragment of D. melanogaster DNA joined to a single copy of pML21, and that the D. melanogaster DNA is, as expected, inserted within the kanamycin resistance fragment of the vehicle. These results were confirmed by electron microscopic heteroduplex mapping of several of the plasmid chimeras.
In the previous experiment, clones harboring plasmid chimeras were identified by direct examination of their DNA. The utility of the pSC101/EcoRI-pSF2124/EcoRI hybrid, pGM706, as a vehicle for recognizing chimeras by replica plating was tested as follows. D KmR TcS clones are shown in Fig. 3 (gels [14] [15] [16] H. Hamer, and C. A. Thomas, Jr., unpublished experiments). It is not known, however, whether the cloned fragments are accurate representations of chromosomal sequences, or if they have undergone rearrangement in E. coil.
The vehicles described here make it possible to clone selectively and to amplify potentially any DNA fragment produced by Sall or BamI. Since these nucleases cleave DNA at different sequences, two adjacent fragments produced by one nuclease will be overlapped by a single fragment produced by the second. This fact should, in principle, allow one to reconstruct the order of these fragments in the chromosome. About 50,000 chimeras would be needed to map the entire D. melanogaster genome.
